Li, Z.-X.; Liu, D.-L.; Hu, L.; Peng, B.-Q.; Qu, X.-Q.; Mu, L.-Y.; Cheng, X.-C.; Qiu, P.; Huang, Y.-X.; Li, X.-R.;
et al. The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study. Cancers 2025, 17, 3574.
https://doi.org/10.3390/cancers17213574
AMA Style
Li Z-X, Liu D-L, Hu L, Peng B-Q, Qu X-Q, Mu L-Y, Cheng X-C, Qiu P, Huang Y-X, Li X-R,
et al. The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study. Cancers. 2025; 17(21):3574.
https://doi.org/10.3390/cancers17213574
Chicago/Turabian Style
Li, Zhao-Xing, Dong-Li Liu, Lei Hu, Bai-Qing Peng, Xiu-Quan Qu, Li-Yuan Mu, Xiao-Chun Cheng, Pu Qiu, Yu-Xuan Huang, Xi-Rui Li,
and et al. 2025. "The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study" Cancers 17, no. 21: 3574.
https://doi.org/10.3390/cancers17213574
APA Style
Li, Z.-X., Liu, D.-L., Hu, L., Peng, B.-Q., Qu, X.-Q., Mu, L.-Y., Cheng, X.-C., Qiu, P., Huang, Y.-X., Li, X.-R., & Kong, L.-Q.
(2025). The Impact of Different Hepatitis B Virus Serological Statuses on the Safety of Different Chemotherapy Regimens in Female Breast Cancer Patients: A Within-Subject Longitudinal Study. Cancers, 17(21), 3574.
https://doi.org/10.3390/cancers17213574
